(Q41822712)

12 October 2017

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone (English)

1 reference

12 October 2017

1 reference

P C Moser

1

1 reference

PubMed ID

2528779

12 October 2017

language of work or name

1 reference

1 January 1989

1 reference

12 October 2017

1 reference

12 October 2017

99

1 reference

12 October 2017

48-53

1 reference

12 October 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00634451

12 October 2017

0 references

cites work

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

1 reference

12 December 2020

Relationships between exploratory behaviour and fear: a review

1 reference

12 December 2020

3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic.

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

A method for measuring monoamine turnover in animals using an irreversible inhibitor of aromatic L-amino acid decarboxylase, DL-α-mono fluoromethyldopa

1 reference

12 December 2020

Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

1 reference

12 December 2020

Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formation.

1 reference

12 December 2020

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

1 reference

12 December 2020

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug

1 reference

12 December 2020

Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

1 reference

12 December 2020

Autonomic and psychic effects of yohimbine hydrochloride

1 reference

12 December 2020

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

1 reference

12 December 2020

Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes

1 reference

12 December 2020

(-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.

1 reference

12 December 2020

MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors

1 reference

12 December 2020

Determinants of emotionality in the rat. I. Situational factors

1 reference

12 December 2020

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

12 December 2020

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00634451

1 reference

PubMed ID

2528779

Dimensions Publication ID

12 October 2017

0 references

1 reference

PubMed ID

2528779